In Silico Technologies: A Strategic Imperative for Accelerating Breakthroughs and Market Leadership for FDA Regulated Products

Dr. Palmer and I presented these slides at the 2024 Scientific Computing Board and Digital Transformation Conference hosted by the FDA.

These slides provide a brief overview of the motivation and key takeaways from the report titled, "In Silico Technologies, a strategic imperative for accelerating breakthroughs and market advantage for FDA regulated products" and how that report came to be.

You can find the report here: https://reaganudall.org/sites/default/files/2024-06/In Silico Technologies_final_1.pdf